CEA (Carcinoembryonic Antigen) (IA0047)

Description

CEA (Carcinoembryonic Antigen) is a tumor marker blood test widely used for monitoring, prognosis, and follow-up of cancers, especially colorectal cancer. It helps assess treatment response, detect disease recurrence, and evaluate cancer progression after surgery or chemotherapy. Elevated CEA levels may also be seen in cancers of the lung, breast, pancreas, stomach, and ovary, as well as in certain non-cancerous conditions such as smoking, liver disease, and inflammation. This test is most effective when interpreted along with clinical findings, imaging studies, and other tumor markers.

Report Time

Fasting

Not Required

Reporting Time

24 Hours

Gender

Male/Female

Age Group

5-99 yrs.

Pre-Test Instructions:

Fasting not mandatory (preferred 6–8 hours if possible)
Avoid hemolyzed or lipemic samples
Smoking can increase CEA levels—clinical correlation required
Best interpreted with imaging and other tumor markers

Parameters Covered

IMMUNOASSAY

- Cancer / Tumor Markers

रु 1,500

✔ Home collection available ✔ No hidden charges

Need help? Call 1800-123-4567

CEA (Carcinoembryonic Antigen) (IA0047)

Description

Report Time

Pre-Test Instructions:

Parameters Covered

Find Tests By Categories